Nkarta (NKTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

NKTX Nkarta

Watchlist

5.590
-0.830-12.93%

Close Sep 12 16:00 ET

5.710
+0.120+2.15%

Pre 07:22 ET

394.42MMarket Cap-2837P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Insiders Who Sold Nkarta Missed Out On 15% Stock Increase
Simply Wall StSep 10 08:32 ET
Nkarta to Participate in Upcoming Investor Conference
Yahoo FinanceSep 3 16:01 ET
Mizuho Securities Maintains Nkarta(NKTX.US) With Buy Rating, Cuts Target Price to $20
Moomoo NewsAug 16 09:31 ET · Ratings
Express News | Nkarta Inc : Mizuho Cuts Target Price to $20 From $25
ReutersAug 16 08:48 ET
Nkarta Is Maintained at Buy by HC Wainwright & Co.
Dow JonesAug 15 06:15 ET
Express News | HC Wainwright & Co. Maintains Buy on Nkarta, Lowers Price Target to $22
BenzingaAug 15 06:05 ET

Comments

Goodjobguys

Aug 1 09:43

7 Cheap But Risky Biotech Stocks? Funds moving from big corporations to Small Caps?

$Immuneering (IMRX.US)$ $SPDR S&P Biotech ETF (XBI.US)$ $iShares Biotechnology ETF (IBB.US)$ $S&P 500 Index (.SPX.US)$ $BioAtla (BCAB.US)$ $Gilead Sciences (GILD.US)$ $Affimed NV (AFMD.US)$ $Instil Bio (TIL.US)$ $Nkarta (NKTX.US)$
Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF XBI 0.05% drop nearly 50%.
The other most-watched exchange-traded fund that tracks the biotech secto...

Trytosaveabit

Jul 24 05:10

Update

$Nkarta (NKTX.US)$ Nkarta Has Initiated An Investigator-sponsored Trial Of NKX019, A Cd19-directed Chimeric Antigen Receptor NK-cell Therapy For Systemic Lupus Erythematosus. In June 2024, Nkarta Initiated Ntrust-1 Phase 1 Trial Of NKX019 For Lupus Nephritis

Meltyy

May 16 01:19

🔔 RA Capital Q1 ‘24* Holdings Released... 🐳

» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$
...

Hashtags

Apr 2 11:14

$Nkarta (NKTX.US)$ jesus have some mercy

Trytosaveabit

Mar 25 05:35

$Nkarta (NKTX.US)$ Nkarta Prices Its Underwritten Offering Of 21M Shares At $10.00/Share And Pre-funded Warrants To Purchase 3M Shares At $9.9999/Warrant, With Gross Proceeds Of Approximately $240.1M

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

NKTX Nkarta

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target